Abstract
Purpose
The purpose of this study was to evaluate the brain, renal, and hepatic effects of three NSAIDs (flunixin meglumine, ketoprofen, and phenylbutazone) when administered IV to clinically normal Iranian fat-tailed sheep.
Methods
The experiments were conducted on twenty clinically normal adult female sheep. Sheep were randomly assigned to four groups: saline (n = 5), flunixin meglumine (n = 5), ketoprofen (n = 5), and phenylbutazone (n = 5). Drug administration was initiated at 8 am on day 1 and continued every 12 h for 12 days. Flunixin meglumine, ketoprofen, and phenylbutazone were administered at dose rate of 2.2, 4, and 4 mg/kg, respectively. Daily blood and urine samples were collected from all sheep for hematologic, enzymes activity, and urinalysis. Immediately after euthanasia, complete necropsy was performed on all sheep and gross lesions were recorded.
Results
Clinical, hematological, serum, and urine analysis and histopatholgical findings were described.
Conclusion
When the use of these compounds is contemplated in clinical cases, the risk of adverse effects and the comparative toxic potential should be considered, along with the efficacy of the compound for the condition being treated.
Similar content being viewed by others
References
Burrows, G.E. 1981. Therapeutic effect of phenylbutazone on experimental acute Escherichia coli endotoxemia in ponies. American Journal of Veterinary Research, 42(1), 94–99.
Burtis, C.A. & Ashwood, E.R. 1994. Tietz Textbook of Clinical Chemistry 2nd ed. WB Saunders.
Carmichael, J. & Shankel, S.W. 1985. Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function. The American Journal of Medicine, 78(6 Pt 1), 992–1000.
Clive, D.M. & Stoff, J.S. 1984. Renal syndromes associated with nonsteroidal antiinflammatory drugs. The New England Journal of Medicine, 310, 563–572.
Dunkle, N.J., Bottoms, G.D., Fessler, J.F., Knox, K. & Roesel, O.F. 1985. Effects of flunixin meglumine on blood pressure and fluid compartment volume changes in ponies given endotoxin. American Journal of Veterinary Research, 46(7), 1540–1544.
Fessler, J.F., Bottoms, G.D., Roesel, O.F., Moore, A.B., Frauenfelder, H.C. & Boon, G.D. 1982. Endotoxin-induced change in hemograms, plasma enzymes, and blood chemical values in anesthetized ponies: effects of flunixin meglumine. American Journal of Veterinary Research (USA), 43(1), 140–144.
Gunson, D.E. 1983. Renal papillary necrosis in horses. Journal of the American Veterinary Medical Association, 182(3), 263–266.
Houdeshell, J.W. & Hennessey, P.W. 1977. A new non-steroidal, anti-inflammatory analgesic for horses. Journal of Equine Medicine and Surgery, 1, 57–63.
Insel, P.A. 1990. Analgesic-antipyretics and Anti-inflammatory Agents: Drugs Employed in the Treatment of Rheumatoid Arthritis and Gout. Pergamon Press, New York.
Kari, F., Bucher, J., Haseman, J., Eustis, S. & Huff, J. 1995. Long-term exposure to the anti-inflammatory agent phenylbutazone induces kidney tumors in rats and liver tumors in mice. Japanese Journal of Cancer Research, 86(3), 252–263.
Lees, P. & Higgins, A.J. 1987. Physiological, biochemical and haematological effects on horses of a phenylbutazone paste. The Veterinary Record, 121(3), 56–60.
MacAllister, C.G., Morgan, S.J., Borne, A.T. & Pollet, R.A. 1993. Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses. Journal of the American Veterinary Medical Association (USA), 202(1), 71–77.
Manoukian, A.V. & Carson, J.L. 1996. Nonsteroidal anti-inflammatory drug-induced hepatic disorders: Incidence and prevention. Drug Safety, 15(1), 64–71.
Meschter, C.L., Gilbert, M., Krook, L., Maylin, G. & Corradino, R. 1990. The effects of phenylbutazone on the intestinal mucosa of the horse: a morphological, ultrastructural and biochemical study. Equine Veterinary Journal (United Kingdom), 22, 255–263.
Moore, J.N., Garner, H.E., Shapland, J.E. & Hatfield, D.G. 1981. Prevention of endotoxin-induced arterial hypoxaemia and lactic acidosis with flunixin meglumine in the conscious pony. Equine Veterinary Journal, 13(2), 95–98.
Moore, J.N., Hardee, M.M. & Hardee, G.E. 1986. Modulation of arachidonic acid metabolism in endotoxic horses: comparison of flunixin meglumine, phenylbutazone, and a selective thromboxane synthetase inhibitor. American Journal of Veterinary Research, 47(1), 110–113.
Mozaffari, A.A., Safarchi, R., Derakhshanfar, A. & Marvili, O.A. 2010. Evaluation of the Effects of Flunixin Meglumine, Ketoprofen and Phenylbutazone Administration on the Brain, Renal and Hepatic Functions in Iranian Cross-Breed Goats. Journal of Biological Sciences, 10(2), 170–173.
Read, W.K. 1983. Renal medullary crest necrosis associated with phenylbutazone therapy in horses. Veterinary Pathology, 20(6), 662–669.
Reilly, J.S. 2001. Euthanasia of animals used for scientific purposes ANCCART, Adelaide.
Snow, D.H., Bogan, J.A., Douglas, T.A. & Thompson, H. 1979. Phenylbutazone toxicity in ponies. The Veterinary Record, 105(2), 26–30.
Tobin, T., Chay, S., Kamerling, S., Woods, W.E., Weckman, T.J., Blake, J.W. & Lees, P. 1986. Phenylbutazone in the horse: a review. Journal of Veterinary Pharmacology and Therapeutics, 9(1), 1–25.
Traub-Dargatz, J.L., Bertone, J.J., Gould, D.H., Wrigley, R.H., Weiser, M.G. & Forney, S.D. 1988. Chronic flunixin meglumine therapy in foals. American Journal of Veterinary Research, 49(1), 7–12.
Vane, J.R. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature: New Biology, 231(25), 232–235.
Vernimb, G.D. & Hennessey, P.W. 1977. Clinical studies on flunixin meglumine in the treatment of equine colic. Joural of Equine Medical Surgury, 1, 111–116.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mozaffari, A.A., Derakhshanfar, A. Evaluation of the brain, renal, and hepatic effects of flunixin meglumine, ketoprofen, and phenylbutazone administration in Iranian fat-tailed sheep. Trop Anim Health Prod 43, 1389–1393 (2011). https://doi.org/10.1007/s11250-011-9866-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11250-011-9866-5